Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

International Myeloma Foundation (IMF) Declares March Myeloma Action Month

International Myeloma Foundation
Posted on: 22 Feb 18
International Myeloma Foundation (IMF) Declares March Myeloma Action Month IMF's Proactive Digital Campaign and Outreach Efforts Asks Every Myeloma Warrior to March Ahead Toward the Cure

PR Newswire

NORTH HOLLYWOOD, Calif., Feb. 22, 2018

NORTH HOLLYWOOD, Calif., Feb. 22, 2018 /PRNewswire-USNewswire/ -- The International Myeloma Foundation (IMF) is harnessing the power of myeloma patients, their families, and the myeloma community at large to raise awareness of the disease during Myeloma Action Month (MAM), starting March 1, 2018. This year's campaign focuses on Myeloma Warriors – those individuals surviving with the disease, supporting loved ones, and helping to find the cure.

Myeloma, a cancer of the blood plasma cells, affects approximately 90,000 people in the U.S. and is the second most common blood cancer. As it is a relatively unknown cancer, myeloma can go undiagnosed until it begins to cause serious health issues. Today with more treatment options available, an early diagnosis is vital for achieving the best outcome for patients. 

This year's Myeloma Action Month campaign hashtag is #myelomawarrior. When using this hashtag to share stories on Twitter, Facebook, Instagram, and Pinterest, these #myelomawarrior posts will stream to the IMF's "Wall of Warriors" at the Myeloma Action Month website This website also houses shareable graphics that participants can post on their social media channels. These graphics are expressed through slogans such as "I am a #myelomawarrior survivor," "I am a #myelomawarrior nurse," "I am a #myelomawarrior caregiver" and more.  

"By collecting patient and caregiver stories," said Susie Durie, President, Founder, and CEO of the IMF, "we are creating a timeless and worldwide forum for myeloma awareness."

Not only will the IMF increase myeloma awareness, it will also promote individuals to take action with impactful results. For example, U.S. primary care doctors may not be familiar with myeloma and are on the front lines of potentially seeing a patient with myeloma. Patients will receive a letter from IMF Chairman Dr. Brian Durie that spells out potential myeloma symptoms and red flags. The letter can be downloaded and personalized.

IMF's Advocacy team once again is working to garner another Federal resolution recognizing March 2018 as "National Multiple Myeloma Awareness Month," and the month will be filled with educational events such as:

  • A daylong Regional Community Workshop to be held in Denver on March 10, and will feature interactive sessions with myeloma experts.
  • An IMF Patient & Family Seminar in Boca Raton, FL, March 16–17 will cover such topics as best therapies for elderly patients, best therapies for patients opting for transplant, management of bone disease, new clinical trials, and more.
  • Post-Myeloma Action Month, an IMF Regional Community Workshop will take place in Nashville on April 21.

To learn about more opportunities to take action, please visit the IMF's Myeloma Action Month website.

Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest foundation focusing specifically on multiple myeloma. The Foundation's reach extends to more than 450,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure by focusing on four key areas: research, education, support, and advocacy. The IMF has conducted more than 250 educational seminars worldwide, maintains a world-renowned InfoLine, and in 2001, established the International Myeloma Working Group (IMWG), a collaborative research initiative focused on improving myeloma treatment options for patients. In 2012, the IMF launched the Black Swan Research Initiative®, a groundbreaking research project aimed at curing myeloma. The IMF can be reached at (800) 452-CURE (2873). The global website is Follow the IMF on Twitter @IMFmyeloma.


Sapna Kumar (818) 487-7455


View original content with multimedia:

SOURCE International Myeloma Foundation

PR Newswire

Last updated on: 22/02/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.